NABULSI AZMI (Chief Operating Officer) sold 3.3% of their position (7.89K shares) of PHATHOM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $52.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/23/2025ACC: 0000950170-25-008353
Officer· Chief Operating Officer
Since Oct 2019
-7.89K
Net shares
Net seller
$52.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.89K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.89K
Price / share
$6.59
Trade value
$51.96K
% of position
3.3%
1/21/2025
241.28K→233.39K
Total
Net shares
−7.89K
Net value
-$51.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/21/2025 | S · Sale | −7.89K | $6.59 | $51.96K | 3.3% | 241.28K | 233.39K |
| Total | −7.89K | -$51.96K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned3.58K
Common Stock
IndirectShares owned785.70K
Total
789.28K indirect789.28K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.58K | Indirect |
| Common Stock | 785.70K | Indirect |
| Total | 789.28K | 789.28K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported